BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 196 filers reported holding BEAM THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.13 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $713 | -24.0% | 29,634 | +0.9% | 0.00% | 0.0% |
| Q2 2023 | $938 | -32.1% | 29,371 | -34.9% | 0.00% | -50.0% |
| Q1 2023 | $1,381 | -36.3% | 45,092 | -18.6% | 0.00% | -33.3% |
| Q4 2022 | $2,167 | -99.9% | 55,407 | +7.2% | 0.00% | -25.0% |
| Q3 2022 | $2,463,000 | +26.9% | 51,698 | +3.1% | 0.00% | +33.3% |
| Q2 2022 | $1,941,000 | -22.5% | 50,148 | +14.8% | 0.00% | 0.0% |
| Q1 2022 | $2,503,000 | -21.6% | 43,689 | +9.1% | 0.00% | 0.0% |
| Q4 2021 | $3,191,000 | -11.9% | 40,039 | -3.8% | 0.00% | -25.0% |
| Q3 2021 | $3,622,000 | -41.6% | 41,622 | -13.7% | 0.00% | -33.3% |
| Q2 2021 | $6,207,000 | +69.9% | 48,228 | +5.6% | 0.01% | +50.0% |
| Q1 2021 | $3,654,000 | -2.0% | 45,650 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $3,727,000 | +353.4% | 45,650 | +36.7% | 0.00% | +300.0% |
| Q3 2020 | $822,000 | +65.7% | 33,400 | +88.7% | 0.00% | 0.0% |
| Q2 2020 | $496,000 | +316.8% | 17,700 | +168.2% | 0.00% | – |
| Q1 2020 | $119,000 | – | 6,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 2,362,635 | $304,095,000 | 29.88% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 224,391 | $28,881,000 | 22.15% |
| HSG Holding Ltd | 796,089 | $102,465,000 | 7.14% |
| DC Investments Management, LLC | 21,010 | $2,704,000 | 6.36% |
| PATHWAY CAPITAL MANAGEMENT, LP | 112,197 | $14,441,000 | 5.74% |
| Redmile Group, LLC | 2,052,506 | $264,178,000 | 3.91% |
| Casdin Capital, LLC | 818,820 | $105,390,000 | 2.68% |
| Darwin Global Management, Ltd. | 126,985 | $16,344,000 | 2.64% |
| Evolutionary Tree Capital Management, LLC | 44,032 | $5,667,000 | 2.61% |
| HHLR ADVISORS, LTD. | 1,845,753 | $237,567,000 | 2.44% |